Big Move For Eliem Therapeutics Inc
Mon, Jun 13, 2022 at 05:30 PM
Eliem Therapeutics Inc (ELYM:NASDAQ) rocketted at $4.98, representing a gain of 24.2%. The stock appeared on our News Catalysts scanner on Mon, May 16, 2022 at 06:45 AM in the 'EARNINGS' category. From Tue, May 31, 2022, the stock recorded 62.50% Up Days and 66.67% Green Days
About Eliem Therapeutics Inc (ELYM:NASDAQ)
Eliem Therapeutics Inc is a clinical-stage biotechnology company.
Top 10 Gainers:
- RISE Education Cayman Ltd (REDU:NASDAQ), 138.46%
- Day One Biopharmaceuticals Inc. (DAWN:NASDAQ), 125.98%
- G Medical Innovations Holdings Ltd. (GMVD:NASDAQ), 88.32%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 68.75%
- OptiNose, Inc. (OPTN:NASDAQ), 41.08%
- AeroClean Technologies Inc. (AERC:NASDAQ), 38%
- Cyngn Inc. (CYN:NASDAQ), 34.43%
- Eliem Therapeutics Inc (ELYM:NASDAQ), 24.19%
- Ekso Bionics Holdings, Inc. (EKSO:NASDAQ), 23.33%
- Belite Bio Inc (BLTE:NASDAQ), 22.91%